In this study, using an ovarian cancer model, we report, for the first time, that: (1) PON2 is overexpressed in early stages (but not in late stages) of ovarian cancer and (2) in mice, overexpression of PON2 reduces ovarian tumor size and volume in a xenograft model. Here, PON2 is linked to ovarian neoplasm.